Walleye Capital LLC

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 1758720 NEW YORK, NY

Position in NAMS

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$3,789,545

+$1,919,073 QoQ

Shares Held

111,819

+91.4% QoQ

Ownership

0.094%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#77

of 197 holders

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. NAMS ranks #29 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	126,005	$33,608,053
2	CYTK	Cytokinetics Inc	239,728	$20,422,428
3	BMRN	Biomarin Pharmaceutical Inc	288,233	$16,492,692
4	IDYA	IDEAYA Biosciences, Inc.	386,183	$14,393,040
5	REGN	Regeneron Pharmaceuticals, Inc.	22,596	$14,089,509
6	RARE	Ultragenyx Pharmaceutical Inc.	334,854	$11,180,775
7	TYRA	Tyra Biosciences, Inc.	347,898	$11,111,862
8	BCAX	Bicara Therapeutics Inc.	353,226	$10,487,279

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,789,545	111,819	+91.4%	Shares	Sole	2026-08-03
2026-03-31	$1,870,472	58,434	-39.3%	Shares	Sole	2026-05-13
2025-12-31	$3,376,835	96,261	+816.2%	Shares	Sole	2026-02-13
2024-12-31	$270,004	10,506	-77.6%	Shares	Sole	2025-02-13
2024-09-30	$779,320	46,947	—	Shares	Sole	2024-11-14
2023-12-31 NAMSW	$70,919	22,658	0.0%	Shares	Sole	2024-02-14
2023-09-30 NAMSW	$43,050	22,658	-29.8%	Shares	Sole	2023-11-21
2023-06-30 NAMSW	$67,419	32,258	+24.1%	Shares	Sole	2023-08-14
2023-03-31 NAMSW	$47,814	25,986	-8.5%	Shares	Sole	2023-05-15
2022-12-31 NAMSW	$24,640	28,388	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.